It was reported that the product is leaking when cytostatica is given to the patient.When they first flush the device with saline, there is no leakage, however, when cyto is given to the patient, the device starts to leak.A section of the device did not remain inside the patient¿s body.The patient required additional procedures due to this occurrence.As cc form: they used another device from another supplier.
|
No physical evaluation could be performed since the device was not returned.However, a document-based investigation was performed.There is no evidence to suggest the product was not made to specifications.Review of the device history record shows no nonconformances which would contribute to this failure mode.There were no other reported complaints for this lot number.Without a returned product to evaluate, a definitive root cause is unable to be confirmed.A quality engineer risk assessment was conducted to assess the risk of this failure mode and concluded a change is not required, thus no risk reduction activities are required at this time.The appropriate internal personnel have been notified and we will continue to monitor for similar complaints.Outcomes attributed to ae should be blank because this is not an adverse event.(b)(4).
|